1. Home
  2. VTEX vs MDXG Comparison

VTEX vs MDXG Comparison

Compare VTEX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$3.63

Market Cap

649.6M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.79

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
MDXG
Founded
1999
2006
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
649.6M
530.2M
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
VTEX
MDXG
Price
$3.63
$3.79
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$5.97
$9.00
AVG Volume (30 Days)
1.3M
1.7M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
$12.78
N/A
Revenue Next Year
$9.63
$13.02
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
19.99
52 Week Low
$2.84
$3.03
52 Week High
$6.82
$7.99

Technical Indicators

Market Signals
Indicator
VTEX
MDXG
Relative Strength Index (RSI) 45.26 56.02
Support Level $2.92 $3.45
Resistance Level $4.21 $7.39
Average True Range (ATR) 0.20 0.13
MACD -0.02 0.05
Stochastic Oscillator 29.88 93.83

Price Performance

Historical Comparison
VTEX
MDXG

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: